Neural tube defects: recent advances, unsolved questions, and controversies
Related Experiment Video
Updated: May 10, 2026

Monitoring the Mechanical Evolution of Tissue During Neural Tube Closure of Chick Embryo
Published on: November 10, 2023
Andrew J Copp1, Philip Stanier, Nicholas D E Greene
1Neural Development Unit and Newlife Birth Defects Research Centre, UCL Institute of Child Health, London, UK. a.copp@ucl.ac.uk
Insights
Neural tube defects (NTDs) are serious birth defects impacting pregnancies. In utero closure of open spina bifida can reduce neurological issues in children.
Area of Science:
- Developmental biology
- Genetics
- Obstetrics
Background:
- Neural tube defects (NTDs) affect approximately 1 in 1000 pregnancies globally.
- Folic acid fortification is a key primary prevention strategy, though not universally implemented.
- Genetic factors, particularly those influencing folate metabolism and cell polarity, are significant risk contributors.
Purpose of the Study:
- To review current understanding of neural tube defect etiology and management.
- To highlight advancements in clinical interventions, such as in utero spina bifida repair.
- To discuss the genetic basis and developmental processes underlying NTDs.
Main Methods:
- Literature review of studies on neural tube defects.
- Analysis of genetic association studies.
- Examination of developmental biology models, particularly mouse studies.
Main Results:
- In utero closure of open spina bifida lesions shows promise in mitigating neurological deficits.
- Genes involved in folate metabolism and planar cell polarity are strongly linked to NTD risk.
- Mouse models differentiate NTDs based on neurulation stages: primary (anencephaly, open spina bifida) versus secondary (spinal dysraphism).
Conclusions:
- Early intervention through in utero surgery can improve outcomes for open spina bifida.
- Understanding genetic predispositions is crucial for risk assessment and prevention.
- Clarifying the sequence of human neural tube closure events is essential for comprehending NTD pathogenesis.
Abstract:
Neural tube defects are severe congenital malformations affecting around one in every 1000 pregnancies. An innovation in clinical management has come from the finding that closure of open spina bifida lesions in utero can diminish neurological dysfunction in children. Primary prevention with folic acid has been enhanced through introduction of mandatory food fortification in some countries, although not yet in the UK. Genetic predisposition accounts for most of the risk of neural tube defects, and genes that regulate folate one-carbon metabolism and planar cell polarity have been strongly implicated. The sequence of human neural tube closure events remains controversial, but studies of mouse models of neural tube defects show that anencephaly, open spina bifida, and craniorachischisis result from failure of primary neurulation, whereas skin-covered spinal dysraphism results from defective secondary neurulation. Other malformations, such as encephalocele, are likely to be postneurulation disorders.
Related Concept Videos
Neurulation
Teratogenicity
